191 related articles for article (PubMed ID: 35658979)
1. Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index.
Ruzsa G; Rencz F; Brodszky V
Health Qual Life Outcomes; 2022 Jun; 20(1):87. PubMed ID: 35658979
[TBL] [Abstract][Full Text] [Related]
2. Discrepancies between the Dermatology Life Quality Index and utility scores.
Rencz F; Baji P; Gulácsi L; Kárpáti S; Péntek M; Poór AK; Brodszky V
Qual Life Res; 2016 Jul; 25(7):1687-96. PubMed ID: 26684848
[TBL] [Abstract][Full Text] [Related]
3. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
4. Is the DLQI appropriate for medical decision-making in psoriasis patients?
Poór AK; Brodszky V; Péntek M; Gulácsi L; Ruzsa G; Hidvégi B; Holló P; Kárpáti S; Sárdy M; Rencz F
Arch Dermatol Res; 2018 Jan; 310(1):47-55. PubMed ID: 29128966
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16.
Szabó Á; Brodszky V; Rencz F
Br J Dermatol; 2022 Mar; 186(3):485-495. PubMed ID: 34724199
[TBL] [Abstract][Full Text] [Related]
6. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
Rencz F; Gulácsi L; Péntek M; Szegedi A; Remenyik É; Bata-Csörgő Z; Bali G; Hidvégi B; Tamási B; Poór AK; Hajdu K; Holló P; Kinyó Á; Sárdy M; Brodszky V
Br J Dermatol; 2020 May; 182(5):1167-1175. PubMed ID: 31419310
[TBL] [Abstract][Full Text] [Related]
7. Normative data and socio-demographic determinants of the dermatology life quality index in a large online sample of the Hungarian population.
Beretzky Z; Rencz F; Brodszky V
Expert Rev Pharmacoecon Outcomes Res; 2022 Oct; 22(7):1153-1161. PubMed ID: 35912947
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
10. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
[TBL] [Abstract][Full Text] [Related]
12. Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states.
Hansen TM; Stavem K; Rand K
Qual Life Res; 2022 Apr; 31(4):1199-1207. PubMed ID: 34718936
[TBL] [Abstract][Full Text] [Related]
13. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
[TBL] [Abstract][Full Text] [Related]
14. Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study.
Schuster B; Ziehfreund S; Schielein MC; Tizek L; Biedermann T; Peifer C; Zink A
Eur J Dermatol; 2022 Apr; 32(2):220-226. PubMed ID: 35866912
[TBL] [Abstract][Full Text] [Related]
15. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
Langenbruch A; Radtke MA; Gutknecht M; Augustin M
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
[TBL] [Abstract][Full Text] [Related]
16. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.
Blome C; Beikert FC; Rustenbach SJ; Augustin M
Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843
[TBL] [Abstract][Full Text] [Related]
17. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).
Rencz F; Mitev AZ; Szabó Á; Beretzky Z; Poór AK; Holló P; Wikonkál N; Sárdy M; Kárpáti S; Szegedi A; Remenyik É; Brodszky V
Qual Life Res; 2021 Aug; 30(8):2375-2386. PubMed ID: 33683650
[TBL] [Abstract][Full Text] [Related]
18. Swedish experience-based value sets for EQ-5D health states.
Burström K; Sun S; Gerdtham UG; Henriksson M; Johannesson M; Levin LÅ; Zethraeus N
Qual Life Res; 2014 Mar; 23(2):431-42. PubMed ID: 23975375
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
[TBL] [Abstract][Full Text] [Related]
20. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
